NCT07623122

Brief Summary

This randomized controlled trial will evaluate the effects of olfactory stimulation and/or multicomponent physical training in adults aged 60 years and older. Eligible participants will be cognitively normal, community-dwelling outpatients recruited from Primary Care and Geriatrics services. After baseline assessment, participants will be randomized to one of four groups: usual care, olfactory training/stimulation, multicomponent physical exercise, or combined olfactory and exercise intervention. Primary and secondary assessments will include olfactory function, cognition, physical function, quality of life, nutritional status, mood, frailty, multimorbidity, polypharmacy, blood-based molecular biomarkers, and exhaled-air biomarkers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 6, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

1.5 years

First QC Date

May 11, 2026

Last Update Submit

May 28, 2026

Conditions

Keywords

Olfactory stimulationOlfactory trainningMulticomponent physical exerciseCognitionOlder adultsBiomarkersExhaled nitric oxideGeriatricsPrecision medicine

Outcome Measures

Primary Outcomes (1)

  • Cognitive Function

    Changes in Cognitive Function assessed with Mini-Mental State Examination (30-point questionnaire; scale of 0 \[worst\] to 30 \[best\]).

    Baseline and Day 30

Secondary Outcomes (14)

  • Olfactory Function (Sniffin' Sticks Test - TDI Score)

    Baseline and Day 30

  • Physical Function

    Baseline and Day 30

  • Mini-Cog - Quick Screening for early dementia detection

    Baseline and day 30

  • Quality of life (QoL)

    Baseline and Day 30

  • Nutritional Status

    Baseline and Day 30

  • +9 more secondary outcomes

Study Arms (4)

Control group.

NO INTERVENTION

Participants assigned to the control group will receive usual care and will not undergo any specific intervention related to olfactory or physical training during the study period.

Olfactory stimulation intervention.

EXPERIMENTAL

Participants assigned to this group will undergo a structured olfactory stimulation program (overnight olfactory enrichment) aimed at improving or maintaining olfactory and congnitive function through repeated exposure to selected odors over the intervention period.

Other: Olfactory stimulation

Multicomponent physical training intervention.

EXPERIMENTAL

Participants in this group will take part in a multicomponent physical training program including exercises targeting strength, balance, and aerobic capacity, adapted to older adults and conducted following established safety guidelines.

Other: Multicomponent physical training

Combined olfactory training/stimulation and multicomponent physical training intervention.

EXPERIMENTAL

Participants assigned to this group will receive a combined intervention consisting of both the olfactory stimulation program and the multicomponent physical training program, delivered concurrently during the study period.

Other: Combined olfactory stimulation and multicomponent physical training

Interventions

Participants assigned to this group will undergo a structured olfactory stimulation program aimed at improving or maintaining olfactory and cognitive function through repeated and exposure to selected odors over the intervention period.

Also known as: Group 1
Olfactory stimulation intervention.

Participants in this group will take part in a multicomponent physical training program including exercises targeting strength, balance, and aerobic capacity, adapted to older adults and conducted following established safety guidelines.

Also known as: Group 2
Multicomponent physical training intervention.

Participants assigned to this group will receive a combined intervention consisting of both the olfactory stimulation program and the multicomponent physical training program, delivered concurrently during the study period.

Also known as: Group 3
Combined olfactory training/stimulation and multicomponent physical training intervention.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥60 years under the care of Primary Care and/or the Geriatrics Service of the Hospital Universitario de Navarra;
  • Normal cognitive function as determined at baseline assessment (Mini-Mental State Examination \[MMSE\] score ≥23; ≥21 for individuals without formal education);
  • Fluent in speaking, reading, and understanding Spanish;
  • Adequate olfactory function;
  • Adequate visual and auditory acuity to complete neuropsychological and computerized assessments;
  • In good general health, with no condition expected to interfere with study participation;
  • Willing and able to comply with study procedures and to participate for the entire study duration;
  • Willing to refrain from the use of scented candles, essential oils, or air fresheners during study participation.

You may not qualify if:

  • Refusal or inability of the participant, primary caregiver, or legal representative to provide informed consent;
  • Diagnosis of a neurodegenerative disease or severe dementia (Global Deterioration Scale \[GDS\] stage 6-7);
  • Conditions affecting the olfactory system (e.g., nasal polyps);
  • Life expectancy \<3 months;
  • History of asthma, allergies, or olfactory-triggered responses producing allergy-like symptoms (e.g., rhinorrhea, lacrimation, sneezing, or skin rash);
  • History of neurological disorders such as Parkinson's disease, multiple sclerosis, brain cyst, tumor, or aneurysm;
  • Significant medical conditions, including uncontrolled diabetes mellitus, uncontrolled hypertension, nutritional deficiencies, or thyroid disorders;
  • History of major psychiatric disorders such as schizophrenia, bipolar disorder, anxiety disorders, or attention-deficit/hyperactivity disorder;
  • History of alcohol or substance abuse or dependence within the past 2 years (DSM-IV criteria), including use of cigarettes, e-cigarettes, cigars, marijuana, or any substance that may produce odors interfering with the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario de Navarra

Pamplona, Navarre, Spain

Location

MeSH Terms

Conditions

FrailtyCognitive Dysfunction

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Nicolas Martinez-Velilla

    Navarrabiomed-Fundación Miguel Servet-Hospital Universitario de Navarra

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2026

First Posted

June 3, 2026

Study Start

June 6, 2024

Primary Completion

December 4, 2025

Study Completion

December 4, 2025

Last Updated

June 3, 2026

Record last verified: 2026-05

Locations